Asymmetric synthesis method of chiral indane diol compound
Synthesis of chiral indandiol by asymmetric transfer of hydrogenation system has solved the shortcomings of the synthesis method of chiral indandiol compounds in the prior art, and achieved efficient and stereoselective multi-unsaturated bond reduction , provides high yield and high stereoselectivity trisubstituted indandiol and its derivatives.
Patent Information
- Application Number
- CN202410907802.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-08
- Publication Date
- 2024-11-12
AI Technical Summary
The existing technology lacks efficient synthesis methods for chiral indandiol compounds, especially the synthesis methods for multi-substituted chiral indandiol and its derivatives, and there is no report, and there is a catalyst amount in the existing asymmetric catalytic methods. Large problems, harsh reaction conditions, solvent restrictions, etc.
The one-pot method of asymmetric transfer hydrogenation system is used to efficiently synthesize tri-substituted indandiol and its derivatives. Through the asymmetric transfer hydrogenation strategy involved in dynamic dynamic dynamic separation, it can achieve carbon-oxygen double bonds, carbon-nitrogen double bonds, and carbon The three-dimensional convergence asymmetric reduction of multiple unsaturated bonds of carbon double bonds uses commercially available catalysts, with a wide range of application, mild reaction conditions and simple operation.
The synthesis of trisubstituted indandiol and its derivatives with high yield (>90%), high stereoselectivity (>95% ee) and high diastereoelectivity (>99:1 dr) was achieved, and the catalyst was used for The amount is small, the reaction time is short, no additional additives are required, the product is easy to derivatize later, and is suitable for active compounds such as drug molecules.
Smart Images

Figure CN118930412A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of organic synthesis, and particularly relates to an asymmetric synthesis method of chiral indanediol compounds. Background Art
[0002] Indanes are an important class of aromatic molecules with important applications in the pharmaceutical field. Studies have shown that indan structures have antioxidant, anti-inflammatory and antibacterial physiological activities. Therefore, it is widely used in the pharmaceutical industry to manufacture drugs such as antioxidants, anti-inflammatory drugs and antibacterial agents. In addition, chiral indan skeletons are also found in anti-depression, anti-AIDS and anti-Parkinson's disease drugs.
[0003] Indane compounds also play an important role in the field of organic synthesis. Functionalized indane molecules often show special reactivity in organic reactions, and compounds containing chiral indane skeletons are also widely used as organic synthesis intermediates or catalysts to achieve a variety of asymmetric reactions. In recent years, the development of simple and efficient methods for synthesizing multi-substituted chiral indane compounds has also attracted the attention of scientists. At present, there are few reports on the synthesis methods of multi-substituted chiral indane compounds, and the main method is the Michael addition cyclization reaction to synthesize multi-substituted chiral indane compounds. For example, the Chinese invention patent with application number CN2013104747067 discloses a method for preparing chiral trisubstituted indane compounds using o-phenylenediol and nitromethane as reactants and chiral multifunctional thiourea as a catalyst. However, there is no report on the synthesis of chiral trisubstituted indanediols and their derivatives.
[0004] Asymmetric catalysis is the most direct and efficient method to obtain chiral compounds, and has been successfully applied in the industrial preparation of natural products, chiral drugs and pesticides. Compared with asymmetric hydrogenation, asymmetric transfer hydrogenation avoids the use of hydrogen, does not require special equipment that can withstand high pressure, has a cheap and easy-to-obtain hydrogen source, milder reaction conditions, simpler operation, and greatly reduced risk. Asymmetric transfer hydrogenation has shown excellent performance in the asymmetric reduction of compounds such as ketones, imines, and activated alkenes, and has become an important branch of asymmetric synthesis. The construction of chiral compounds through asymmetric transfer hydrogenation strategies is currently mainly focused on (dynamic kinetic resolution) single or double reduction of unsaturated bonds, and there are no reports of one-pot methods for achieving multiple asymmetric reductions including triple reductions.
[0005] Therefore, there is an urgent need for an efficient method for synthesizing chiral indanediol compounds. Summary of the invention
[0006] The present invention aims to solve at least one of the technical problems existing in the above-mentioned prior art. To this end, the present invention provides an asymmetric synthesis method of chiral indanediol compounds.
[0007] The present application adopts an asymmetric transfer hydrogenation system to synthesize trisubstituted indanediol and its derivatives (called chiral indanediol compounds) in a one-pot method with high efficiency and high stereoselectivity. The advantages are: (1) the raw materials are easily available; (2) the catalyst is commercially available; and the amount of catalyst used is small; (3) the operation is simple, and no high-pressure catalytic hydrogenation system is used, so the safety factor is high; (4) the stereoconvergent asymmetric reduction of three unsaturated bonds is achieved in a one-pot method; (5) the reaction yield is high (>90%), the diastereoselectivity is high (>99:<1dr), and the reaction stereoselectivity is high (>95%ee); (6) the product is easy to be later derivatized into active compounds such as drug molecules.
[0008] Compared with the Chinese invention patent with application number CN2013104747067, the asymmetric synthesis method of the present invention has the following advantages: (1) higher conversion efficiency, with most separation yields exceeding 90%; (2) less catalyst dosage, with most catalyst dosage being 1 mol%, while the catalyst dosage of the Chinese invention patent with application number CN2013104747067 must exceed 15 mol%; (3) the solvent of the Chinese invention patent with application number CN2013104747067 is only aromatic solvents, while the asymmetric synthesis method of the present invention is applicable to a wider range of solvents, with most protic solvents and aprotic solvents being applicable to the asymmetric synthesis method of the present invention; (4) shorter reaction time, with most reactions being completed within 10 hours; and (5) no additional molecular sieve or the like is required as an additive.
[0009] The asymmetric synthesis method of the present invention realizes the asymmetric reduction of multiple unsaturated bonds including carbon-oxygen double bonds, carbon-nitrogen double bonds and carbon-carbon double bonds for the first time through a single catalytic system, and constructs multiple continuous stereo centers in a stereo-convergent manner.
[0010] The present invention provides a method for asymmetric reduction of indanedione compounds by asymmetric transfer hydrogenation strategy involving dynamic kinetic resolution, and efficiently constructing 1,3-indandiol and its derivatives containing three consecutive chiral centers. The present invention has mild reaction conditions, simple operation, and obtains the target compound with high yield and high stereoselectivity, and the substrate has a wide range of application and the product has high application value.
[0011] The present invention provides an asymmetric synthesis method of chiral indanediol compounds, comprising the following steps:
[0012] A substrate, a catalyst, a hydrogen source and a solvent are mixed and reacted to obtain the chiral indandiol compound;
[0013] The structural formula of the substrate is
[0014] The structural formula of the chiral indandiol compound is
[0015] Wherein, R is selected from any one of phenyl, benzyl, benzyloxy, bromophenyl, trifluoromethylphenyl, and pyridine;
[0016] X and Y are independently selected from O, N or C.
[0017] Preferably, the substrate is selected from at least one of the following compounds:
[0018]
[0019] Preferably, the chiral indanediol compound is selected from at least one of the following compounds:
[0020]
[0021] Preferably, the catalyst comprises any one of the following:
[0022]
[0023] "Cat-1" indicates the first catalyst, "Cat-2" indicates the second catalyst, and "Cat-3" indicates the third catalyst. The catalyst is an asymmetric transfer hydrogenation catalyst.
[0024] Preferably, the molar amount of the catalyst is less than 1% of the molar amount of the substrate, and more preferably, the molar amount of the catalyst is 0.2-1% of the molar amount of the substrate. The present invention can efficiently catalyze the reaction using a small amount of catalyst.
[0025] Preferably, the molar volume ratio of the substrate to the hydrogen source is 0.1 mmol:(50-100) μL, and more preferably 0.1 mmol:(60-100) μL.
[0026] Preferably, the hydrogen source is selected from at least one of formic acid / triethylamine azeotropic mixture, formic acid / triethylenediamine, formic acid, potassium formate, sodium formate, and isopropanol.
[0027] Preferably, the formic acid / triethylamine azeotropic mixture comprises a formic acid / triethylamine azeotropic mixture (volume ratio is 5:2) or a formic acid / triethylamine azeotropic mixture (volume ratio is 1:1).
[0028] Preferably, the solvent is selected from an aprotic solvent or a protic solvent.
[0029] Preferably, the aprotic solvent includes at least one of 1,2-dichloroethane, tetrahydrofuran, toluene and acetonitrile.
[0030] Preferably, the protic solvent includes at least one of water, methanol, ethanol, trifluoroethanol, isopropanol, hexafluoroisopropanol, and tert-butanol.
[0031] Preferably, the reaction temperature is 40-120°C, and further preferably, the reaction temperature is 60-90°C.
[0032] Preferably, the reaction time is 1-48 hours, and more preferably, the reaction time is 4-24 hours.
[0033] Preferably, after the reaction is completed, a separation and purification process is further included, for example, silica gel is directly added to the mixed solution after the reaction is completed, the solvent is spin-dried, and the mixture is purified by column chromatography (the volume ratio of ethyl acetate to petroleum ether is 1:16 to 1:4).
[0034] The reaction process of the asymmetric synthesis method of chiral indanediol compounds is as follows:
[0035]
[0036] Application of asymmetric synthesis methods in the field of drug synthesis.
[0037] Compared with the prior art, the beneficial effects of the present invention are as follows:
[0038] The present application adopts an asymmetric transfer hydrogenation system to synthesize trisubstituted indanediol and its derivatives (called chiral indanediol compounds) in a one-pot method with high efficiency and high stereoselectivity. The advantages are: (1) the raw materials are easily available; (2) the catalyst is commercially available; and the amount of catalyst used is small; (3) the operation is simple, and no high-pressure catalytic hydrogenation system is used, which has a high safety factor; (4) the stereoconvergent asymmetric reduction of three unsaturated bonds is achieved in a one-pot method; (5) the reaction yield is high (>90%), with the highest yield being >99.9%, the diastereoselectivity is high (>99:<1dr), and the reaction stereoselectivity is high (>95%ee); (6) the product is easy to be later derivatized into active compounds such as drug molecules.
[0039] Therefore, the present invention provides a synthesis method for obtaining trisubstituted indanediol and its derivatives with high efficiency, high yield, high enantioselectivity and high stereoselectivity. BRIEF DESCRIPTION OF THE DRAWINGS
[0040] Figure 1 The H NMR spectrum of compound 2a prepared in Example 1;
[0041] Figure 2 The carbon NMR spectrum of compound 2a prepared in Example 1;
[0042] Figure 3 The H NMR spectrum of compound 2b prepared in Example 2;
[0043] Figure 4 The carbon NMR spectrum of compound 2b prepared in Example 2;
[0044] Figure 5 The H NMR spectrum of compound 2c prepared in Example 3;
[0045] Figure 6 The carbon NMR spectrum of compound 2c prepared in Example 3;
[0046] Figure 7 The H NMR spectrum of compound 2d prepared in Example 4;
[0047] Figure 8 The carbon NMR spectrum of compound 2d prepared in Example 4;
[0048] Fig. 9 This is the hydrogen nuclear magnetic resonance spectrum of compound 2e prepared in Example 5;
[0049] Fig.10 The carbon NMR spectrum of compound 2e prepared in Example 5;
[0050] Fig.11 This is the hydrogen nuclear magnetic resonance spectrum of compound 2f prepared in Example 6;
[0051] Fig.12 This is the carbon NMR spectrum of compound 2f prepared in Example 6. DETAILED DESCRIPTION
[0052] In order to make the technical scheme of the present invention more clearly understood by those skilled in the art, the following embodiments are listed for illustration. It should be pointed out that the following embodiments do not limit the protection scope of the present invention.
[0053] Unless otherwise specified, the raw materials, reagents or devices used in the following examples can be obtained from conventional commercial sources or by existing known methods.
[0054] The technical means for structural confirmation are all common technical means known to those skilled in the art, such as nuclear magnetic resonance technology and high-resolution mass spectrometry. The technical means for chiral optical property confirmation are all common technical means known to those skilled in the art, such as high performance liquid chromatography and optical polarimetry.
[0055] Taking the molar ratio of substrate to catalyst S / C=100:1 as an example, the asymmetric synthesis method of the chiral indanediol compound comprises the following steps:
[0056] Weigh the substrate (0.1 mmol), catalyst (1 mol% of the substrate), 1 mL of solvent, add 100 μL of hydrogen source HCOOH / Et3N (volume ratio of 5:2), 60-90° C., react for 4-24 hours. After the reaction is completed, add silica gel directly to the reaction solution, spin-dry the solvent, and purify by column chromatography (ethyl acetate: petroleum ether = 1:4, 1:4 is a volume ratio) to obtain chiral indanediol compounds.
[0057] Yield (%) of chiral indanediol compounds = (actual yield / theoretical yield) x 100%.
[0058] Example 1
[0059] The asymmetric synthesis method of chiral indandiol compounds, the reaction process is as follows:
[0060]
[0061] The above substrate 1a (32 mg, 0.1 mmol) and the catalyst Cat-1 0.07 mg were accurately weighed, 1 mL of isopropanol (IPA) was added, 100 μL of HCOOH / Et3N mixture (volume ratio of 5:2) was added, and the mixture was placed in a 10 mL reaction tube equipped with a magnetic stirrer, and reacted at 90°C for 12 hours. After the reaction was completed, silica gel was added to the reaction solution, the solvent was dried by spin drying, and the reaction solution was purified by column chromatography (the volume ratio of ethyl acetate to petroleum ether was 1:4). After purification, 30 mg of the product (2a) was obtained, and the product was a white solid. The yield of the reaction was 90%.
[0062] The structural characterization results and chiral optical detection results of product (2a) are: 1 H NMR (400MHz, CDCl3) δ7.48–7.30(m,8H),7.14–6.97(m,5H),5.16(d,J=7.3Hz ,1H),5.04(d,J=5.4Hz,1H),3.11(qd,J=13.8,8.0Hz,2H),2.44–2.34(m,1H). 13 C NMR (101 MHz, CDCl3) δ 157.44, 155.55, 145.37, 142.79, 135.65, 130.16, 129.74, 129.41, 128.66, 124.89, 124.21, 123.13, 119.20, 118.72, 78.66, 73.69, 57.31, 32.18. ee value: >99.9%; dr value: >99:<1 (HPLC conditions: Daicel AD-H column, n-hexane / isopropanol = 92:8, flow rate 1.0 mL / min, detection wavelength = 210 nm, temperature = 31 °C).
[0063] Example 2
[0064] The asymmetric synthesis method of chiral indandiol compounds, the reaction process is as follows:
[0065]
[0066] The above substrate 1b (28 mg, 0.2 mmol) and the catalyst Cat-2 (0.07 mg) were accurately weighed, 1 mL of isopropanol (IPA) was added, 100 μL of HCOOH / Et3N mixture (volume ratio of 5:2) was added, and the mixture was placed in a 10 mL reaction tube equipped with a magnetic stirrer, and reacted at 80°C for 12 hours. After the reaction was completed, silica gel was added to the reaction solution, the solvent was dried by spin drying, and the reaction solution was purified by column chromatography (the volume ratio of ethyl acetate to petroleum ether was 1:6). After purification, 27 mg of the product (2b) was obtained, and the product was a white solid. The yield of the reaction was 95%.
[0067] The structural characterization results and chiral optical detection results of the product (2b) are: 1 H NMR (400MHz, CDCl3) δ8.20(s,2H),7.55(s,2H),7.35(s,4H),5.15(s,1H),4.92(s,1H),3.28(s,1H),3.19(s,1H),2.37(s,1H). 13 C NMR (101 MHz, CDCl3) δ 149.05, 146.52, 145.14, 142.58, 129.93, 129.63, 128.87, 124.80, 124.18, 123.75, 78.58, 73.00, 57.20, 32.78. ee value: >99.9%; dr value: >99:<1 (HPLC conditions: Daicel AD-H column, n-hexane / isopropanol = 92:8, flow rate = 1.0 mL / min, detection wavelength = 210 nm, temperature = 31 °C).
[0068] Example 3
[0069] The asymmetric synthesis method of chiral indandiol compounds, the reaction process is as follows:
[0070]
[0071] The above substrate 1c (26 mg, 0.1 mmol) and the catalyst Cat-3 0.07 mg were accurately weighed, 1 mL of isopropanol (IPA) was added, 100 μL of HCOOH / Et3N mixture (volume ratio of 5:2) was added, and the mixture was placed in a 10 mL reaction tube equipped with a magnetic stirrer, and reacted at 90°C for 24 hours. After the reaction was completed, silica gel was added to the reaction solution, the solvent was dried by spin drying, and the reaction solution was purified by column chromatography (the volume ratio of ethyl acetate to petroleum ether was 1:6). After purification, 25 mg of the product (2c) was obtained, and the product was a white solid. The yield of the reaction was 93%.
[0072] The structural characterization results and chiral optical detection results of the product (2c) are: 1 H NMR (400MHz, CDCl3) δ7.45–7.28(m,6H),6.90(d,J=9.5Hz,2H),5.12(s,1H),5.02(s,1H),3.81(s,3H),3.07(s,2H),2.39(s,1H). 13 C NMR (101 MHz, CDCl3) δ 158.06, 145.42, 142.78, 132.68, 129.81, 129.37, 128.60, 124.89, 124.20, 114.14, 78.70, 77.24, 73.85, 57.32, 55.30, 32.07. ee value: 98%; dr value: >99:<1 (HPLC conditions: Daicel AD-H column, n-hexane / isopropanol = 92:8, flow rate = 1.0 mL / min, detection wavelength = 210 nm, temperature = 31 °C).
[0073] Example 4
[0074] The asymmetric synthesis method of chiral indandiol compounds, the reaction process is as follows:
[0075]
[0076] The above substrate 1d (31 mg, 0.1 mmol) and the catalyst Cat-1 0.07 mg were accurately weighed, 1 mL of isopropanol (IPA) was added, 100 μL of HCOOH / Et3N mixture (volume ratio of 5:2) was added, and the mixture was placed in a 10 mL reaction tube equipped with a magnetic stirrer, and reacted at 90°C for 12 hours. After the reaction was completed, silica gel was added to the reaction solution, the solvent was dried by spin drying, and the reaction solution was purified by column chromatography (the volume ratio of ethyl acetate to petroleum ether was 1:4). After purification, 30 mg of the product (2d) was obtained, and the product was a white solid. The yield of the reaction was 94%.
[0077] The structural characterization results and chiral optical detection results of the product (2d) are: 1H NMR (400MHz, CDCl3) δ7.54–7.17(m,8H),5.14(d,J=7.4Hz,1H),4.98(d,J=5.4Hz,1H),3.17– 3.00(m,2H),2.35(ddt,J=9.7,7.4,5.8Hz,1H),1.78(s,1H),1.50(s,1H),1.36–1.24(m,2H). 13 C NMR (101 MHz, CDCl3) δ 145.27, 142.72, 139.83, 131.65, 130.76, 129.47, 128.72, 124.85, 124.20, 119.93, 78.57, 73.38, 57.17, 32.26. ee value: 98%; dr value: >99:<1 (HPLC conditions: Daicel AD-H column, n-hexane / isopropanol = 92:8, flow rate = 1.0 mL / min, detection wavelength = 210 nm, temperature = 31 °C).
[0078] Example 5
[0079] The asymmetric synthesis method of chiral indandiol compounds, the reaction process is as follows:
[0080]
[0081] The above substrate 1e (29 mg, 0.1 mmol) and catalyst Cat-2 (0.07 mg) were accurately weighed, 1 mL of isopropanol (IPA) was added, 100 μL of HCOOH / Et3N mixture (volume ratio of 5:2) was added, and placed in a 10 mL reaction tube equipped with a magnetic stirrer, and reacted at 90°C for 10 hours. After the reaction was completed, silica gel was added to the reaction solution, the solvent was spin-dried, and the reaction solution was purified by column chromatography (the volume ratio of ethyl acetate to petroleum ether was 1:1). After purification, 28 mg of product 2e was obtained, and the product was a white solid. The yield of the product was 96%.
[0082] The structural characterization results and chiral optical detection results of the product (2e) are: 1 H NMR (400MHz, CDCl3) δ7.37(s,5H),7.25(s,1H),6.87(s,2H),5.14(s,1H),5.03(s,1H),4.53(s,1H),3.04(s,2H),2.38(s,1H),1.35(s,6H). 13C NMR (101 MHz, CDCl3) δ 156.36, 145.42, 142.78, 132.50, 129.80, 129.35, 128.58, 124.90, 124.19, 116.20, 78.71, 73.89, 69.98, 57.26, 32.09, 22.13. ee value: 97%; dr value: >99:<1 (HPLC conditions: Daicel AD-H column, n-hexane / isopropanol = 92:8, flow rate = 1.0 mL / min, detection wavelength = 210 nm, temperature = 31 °C).
[0083] Example 6
[0084] The asymmetric synthesis method of chiral indandiol compounds, the reaction process is as follows:
[0085]
[0086] Accurately weigh the above substrate 1f (30 mg, 0.1 mmol), catalyst Cat-2 0.07 mg, add 1 mL isopropanol (IPA), add 100 μL HCOOH / Et3N mixture (volume ratio of 5:2), place in a 10 mL reaction tube equipped with a magnetic stirrer, react at 90°C for 10 hours, after the reaction is completed, add silica gel to the reaction solution, spin dry the solvent, and purify by column chromatography (volume ratio of ethyl acetate to petroleum ether is 1:5), after purification, obtain product 2f 28 mg, the product is a white solid. The yield of the reaction is 91%.
[0087] The structural characterization results and chiral optical detection results of the product (2f) are: 1 H NMR (400MHz, CDCl3) δ7.60(d,J=8.1Hz,2H),7.56–7.29(m,6H),5.16(d,J=7.4Hz,1H),4.97(d,J=5.4Hz ,1H),3.23(dd,J=13.6,10.0Hz,1H),3.14(dd,J=13.6,5.9Hz,1H),2.38(ddt,J=10.0,7.5,5.7Hz,1H). 13 C NMR (101 MHz, CDCl3) δ 145.24, 142.70, 129.54, 129.34, 128.79, 125.49, 125.45, 124.81, 124.19, 78.62, 73.27, 57.27, 32.69. ee value: >99.9%; dr value: >99:<1 (HPLC conditions: Daicel AD-H column, n-hexane / isopropanol = 92:8, flow rate = 1.0 mL / min, detection wavelength = 210 nm, temperature = 31 °C).
[0088] Comparative Example 1
[0089] Compared with Example 1, after the hydrogen source HCOOH / Et3N mixture (volume ratio of 5:2) was replaced by an equal volume of isopropanol in Comparative Example 1, no reaction could be carried out and the target product could not be synthesized.
[0090] Figure 1 The H NMR spectrum of compound 2a prepared in Example 1; Figure 2 The carbon NMR spectrum of compound 2a prepared in Example 1; Figure 3 The H NMR spectrum of compound 2b prepared in Example 2; Figure 4 The carbon NMR spectrum of compound 2b prepared in Example 2; Figure 5 The H NMR spectrum of compound 2c prepared in Example 3; Figure 6 The carbon NMR spectrum of compound 2c prepared in Example 3; Figure 7 The H NMR spectrum of compound 2d prepared in Example 4; Figure 8 The carbon NMR spectrum of compound 2d prepared in Example 4; Fig. 9 This is the hydrogen nuclear magnetic resonance spectrum of compound 2e prepared in Example 5; Fig.10 The carbon NMR spectrum of compound 2e prepared in Example 5; Fig.11 This is the hydrogen nuclear magnetic resonance spectrum of compound 2f prepared in Example 6; Fig.12 This is the carbon NMR spectrum of compound 2f prepared in Example 6. Figure 1 “f1(ppm)” represents chemical shift.
[0091] It is noted that the above embodiments are only used to illustrate the technical solutions of the present invention rather than to limit the present invention. Although the present invention has been described with reference to the preferred embodiments of the present invention, it should be understood by those skilled in the art that various changes can be made in form and details without departing from the spirit and scope of the present invention, which all fall within the scope of protection claimed by the present invention.
Claims
1. A method for asymmetric synthesis of chiral indanediol compounds, It is characterized in that The following steps are involved: A substrate, a catalyst, a hydrogen source and a solvent are mixed and reacted to obtain the chiral indandiol compound; The structural formula of the substrate is The structural formula of the chiral indandiol compound is Wherein, R is selected from any one of phenyl, benzyl, benzyloxy, bromophenyl, trifluoromethylphenyl, and pyridine; X and Y are independently selected from O, N or C.
2. The asymmetric synthesis method according to claim 1, It is characterized in that The catalyst includes any of the following:
3. The asymmetric synthesis method according to claim 1, It is characterized in that The molar amount of the catalyst is less than 1% of the molar amount of the substrate.
4. The asymmetric synthesis method according to claim 1, It is characterized in that The molar volume ratio of the substrate to the hydrogen source is 0.1 mmol: (50-120) μL.
5. The asymmetric synthesis method according to claim 1, It is characterized in that The hydrogen source is selected from at least one of a formic acid / triethylamine azeotropic mixture, a formic acid / triethylenediamine mixture, formic acid, potassium formate, sodium formate, and isopropanol.
6. The asymmetric synthesis method according to claim 1, It is characterized in that The solvent is selected from an aprotic solvent or a protic solvent.
7. The asymmetric synthesis method according to claim 6, It is characterized in that The aprotic solvent includes at least one of 1,2-dichloroethane, tetrahydrofuran, toluene, and acetonitrile; and / or the protic solvent includes at least one of water, methanol, ethanol, trifluoroethanol, isopropanol, hexafluoroisopropanol, and tert-butanol.
8. The asymmetric synthesis method according to claim 1, It is characterized in that The reaction temperature is 40-120° C.; and / or the reaction time is 1-48 hours.
9. The asymmetric synthesis method according to any one of claims 1 to 8, It is characterized in that After the reaction is completed, a separation and purification process is also included.
10. Application of the symmetrical synthesis method according to any one of claims 1 to 9 in the field of drug synthesis.
